A Brighter Future — ABF Wellness ShopABF Wellness ShopWellness Shop
Research LibraryPeptide Research

Sermorelin

Clinical/Regulatory Review Required

A growth-hormone-releasing hormone analogue with historical pediatric use; newer adult wellness applications lack strong evidence.

Limited human evidenceLast reviewed October 27, 2026

Sermorelin is a synthetic peptide corresponding to the first 29 amino acids of human growth hormone-releasing hormone (GHRH). It acts on the pituitary gland to stimulate the body's release of growth hormone. Growth hormone contributes to childhood growth, metabolism, and the regulation of several physiological processes. Sermorelin's effect depends on the responsiveness of the pituitary gland.

Medical information disclaimer

This page is educational only and is not medical advice. It does not describe an approved treatment for every individual and does not guarantee that any product is available for purchase. Investigational compounds are not offered for sale or treatment booking through this storefront. FDA approval applies to specific drug products and indications, not automatically to every formulation containing the same ingredient.

References & Further Reading

  • FDA Geref withdrawal determination — U.S. Food and Drug Administration / GovInfosource
  • Endocrine Society scientific statement on hormones and aging — Endocrine Society

This entry was last reviewed on October 27, 2026 and requires clinical review before publication. ABF's medical and legal advisers may revise research findings and regulatory information as evidence changes.

Related Research

BPC-157

Investigational Peptide

TB-500

Investigational Peptide

CJC-1295 + Ipamorelin

Investigational Combination